Skip to content
Disclosery

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 40 holding rows worth $476,910,569.

Accession
0001958125-25-000007
Filer
CIK 1958125
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 40 entries on the cover page, a total value of $476,910,569 stated on the cover page (in dollars after the unit check, H1), rows summing to $476,910,569 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Eli Lilly and Company532457108COM53,916$42,029,139dollars as filed
BRIDGEBIO PHARMA INC10806X102COM927,711$40,058,561dollars as filed
SOLENO THERAPEUTICS INC834203309COM409,944$34,345,108dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR179,926$31,055,228dollars as filed
Intuitive Surgical,Inc.46120E602COM56,674$30,797,218dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock390,932$30,574,792dollars as filed
Gilead Sciences,Inc.375558103COM226,875$25,153,631dollars as filed
Boston Scientific Corporation101137107COM229,046$24,601,831dollars as filed
CYTOKINETICS INC23282W605COM NEW601,439$19,871,545dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM2,104,512$19,708,755dollars as filed
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,170,372$19,615,435dollars as filed
CORCEPT THERAPEUTICS INC218352102COM239,125$17,551,775dollars as filed
NATERA INC COM632307104Stock97,297$16,437,355dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock1,396,445$16,268,584dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM746,527$13,907,798dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY670,575$13,907,725dollars as filed
ADMA BIOLOGICS INC000899104COM569,704$10,374,310dollars as filed
HALOZYME THERAPEUTICS INC COM40637H109Stock191,529$9,963,339dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM213,402$7,759,297dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock162,596$7,674,531dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK672,290$6,447,261dollars as filed
UNIQURE NVN90064101SHS417,443$5,819,155dollars as filed
GENEDX HOLDINGS CORP81663L200COM CL A61,507$5,677,711dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,626,370$4,927,901dollars as filed
OUTSET MED INC690145206COM NEW166,666$3,201,654dollars as filed
SEPTERNA INC COM81734D104Stock294,360$3,111,385dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK330,337$3,068,831dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock215,314$2,086,393dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM388,303$1,957,047dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK586,909$1,801,811dollars as filed
DISC MEDICINE INC COM254604101Stock30,661$1,623,807dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK188,304$1,295,532dollars as filed
BICARA THERAPEUTICS INC055477103COM97,800$908,562dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$782,910dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK146,013$629,316dollars as filed
HYPERFINE INC44916K106Common Stock760,035$546,921dollars as filed
Mersana Therapeutics Inc59045L106Common Stock1,567,413$463,954dollars as filed
ATAIBECKLEY INCN0731H103Equity196,858$431,119dollars as filed
FRACTYL HEALTH INC35168W103COM214,236$347,062dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW14,718$126,280dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-25-000007this filing2025-08-14acceptance time not in the bulk data set